Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Harding

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chest|October 1, 1973
Digitalis as an antianginal agentP R Harding, W S Aronow, J Eisenman
Chest|May 1, 1973
Diurnal variation of plasma catecholamines and systolic time intervalsW S Aronow, P R Harding, V DeQuattro, et al.
Canadian Journal of Zoology|December 1, 1974
Radio tracking of small mammals using a grid of overhead wire antennasF S Chute, W A Fuller, P R Harding, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Effect of halofenate on serum uric acidW S Aronow, P R Harding, M Khursheed, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Effect of halofenate on exercise performance in coronary heart diseaseW S Aronow, P R Harding, M Khursheed, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Effect of halofenate on serum lipidsW S Aronow, P R Harding, M Khursheed, et al.
Chest|June 1, 1973
Treatment of acute arrhythmias with orally administered tolamololW S Aronow, L L Johnson, J S Vangrove, et al.
Clinical Pharmacology and Therapeutics|November 1, 1972
Treatment of arrhythmias with tolamidolW S Aronow, P R Harding, W H Nelson, et al.
Clinical Pharmacology and Therapeutics|January 1, 1974
Halofenate, serum lipids, and exercise performance in coronary heart diseaseW S Aronow, J S Vangrow, W H Nelson, et al.
Current Therapeutic Research, Clinical and Experimental|December 1, 1973
Halofenate: an effective hypolipemia- and hypouricemia-inducing drugW S Aronow, J S Vangrow, W H Nelson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chest|October 1, 1973
Digitalis as an antianginal agentP R Harding, W S Aronow, J Eisenman
Chest|May 1, 1973
Diurnal variation of plasma catecholamines and systolic time intervalsW S Aronow, P R Harding, V DeQuattro, et al.
Canadian Journal of Zoology|December 1, 1974
Radio tracking of small mammals using a grid of overhead wire antennasF S Chute, W A Fuller, P R Harding, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Effect of halofenate on serum uric acidW S Aronow, P R Harding, M Khursheed, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Effect of halofenate on exercise performance in coronary heart diseaseW S Aronow, P R Harding, M Khursheed, et al.
Clinical Pharmacology and Therapeutics|May 1, 1973
Effect of halofenate on serum lipidsW S Aronow, P R Harding, M Khursheed, et al.
Chest|June 1, 1973
Treatment of acute arrhythmias with orally administered tolamololW S Aronow, L L Johnson, J S Vangrove, et al.
Clinical Pharmacology and Therapeutics|November 1, 1972
Treatment of arrhythmias with tolamidolW S Aronow, P R Harding, W H Nelson, et al.
Clinical Pharmacology and Therapeutics|January 1, 1974
Halofenate, serum lipids, and exercise performance in coronary heart diseaseW S Aronow, J S Vangrow, W H Nelson, et al.
Current Therapeutic Research, Clinical and Experimental|December 1, 1973
Halofenate: an effective hypolipemia- and hypouricemia-inducing drugW S Aronow, J S Vangrow, W H Nelson, et al.
Pageof 1